John M. Evans's Net Worth
$57 Million
Who is John M. Evans?
John M. Evans has an estimated net worth of $57 Million. This is based on reported shares across multiple companies, which include Beam Therapeutics Inc., and Verve Therapeutics, Inc..
SEC CIK
John M. Evans's CIK is 0001786304
Past Insider Trading and Trends
2021 was John M. Evans's most active year for acquiring shares with 12 total transactions. John M. Evans's most active month to acquire stocks was the month of February. 2022 was John M. Evans's most active year for disposing of shares, totalling 43 transactions. John M. Evans's most active month to dispose stocks was the month of June. 2024 saw John M. Evans paying a total of $3,782,000.00 for 155,000 shares, this is the most they've acquired in one year. In 2024 John M. Evans cashed out on 60,000 shares for a total of $1,519,800.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Beam Therapeutics Inc. (BEAM) Snapshot price: $27.66
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.67% | -60.00K |
$24.50 | -$1,470,156.00 | 1M |
Jun 27
| |||
Form 4
| -1.68% | -18.10K |
$32.13 | -$581,617.26 | 1.06M |
Apr 1 - Apr 3
| |||
Form 4
| +0.85% | 17.5K |
$33.86 | -$2,031,402.00 | 2.07M |
Mar 28 - Mar 31
| |||
Form 4
| -5.37% | -60.00K |
$25.33 | -$1,519,800.00 | 1.06M |
Jan 31
| |||
Form 4
| -1.03% | -11.65K |
$29.63 | -$345,334.01 | 1.12M |
Apr 3 - Apr 4
| |||
Form 4
| +6.64% | 70.33K |
$7.22 | $99,997.00 | 1.13M |
Jan 31 - Mar 31
| |||
Form 4
| -4.13% | -50.00K |
$46.34 | -$2,316,428.33 | 1.16M |
Scheduled
|
Oct 31
| ||
Form 4
| -3.96% | -50.00K |
$65.77 | -$3,288,081.17 | 1.21M |
Scheduled
|
Jul 28
| ||
Form 4
| +0.75% | 9.45K |
$20.15 | -$1,761,863.07 | 1.26M |
Scheduled
|
Apr 28
| ||
Form 4
| +4.81% | 49.99K |
$59.11 | -$370,087.71 | 1.09M |
Mar 31
| |||
Form 4/A
| +3.27% | 38K |
$33.94 | -$3,238,903.07 | 1.2M |
Scheduled
|
Nov 16 - Jan 31
| ||
Form 4
| -1.62% | -20.00K |
$42.42 | -$3,968,737.07 | 1.22M |
Scheduled
|
Oct 6
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| -0.64% | -8.00K |
$50.26 | -$1,977,384.32 | 1.24M |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$54.45 | -$2,671,076.34 | 1.02M |
Scheduled
|
Jul 7
| ||
Form 4
| +0.01% | 96 |
—
|
—
| 1.02M |
Jun 25 - Jun 29
| |||
Form 4
| -1.83% | -19.00K |
$35.76 | -$1,756,035.61 | 1.02M |
Scheduled
|
Apr 21 - Apr 23
| ||
Form 4
| +0.01% | 97 |
—
|
—
| 1.04M |
Mar 18 - Mar 31
| |||
Form 4
| +7.15% | 69.38K |
—
|
—
| 1.04M |
Mar 31
| |||
Form 4
| -2.25% | -22.30K |
$84.94 | -$1,894,124.84 | 970.96K |
Scheduled
|
Dec 30
| ||
Form 4
| +13.09% | 115K |
$1.03 | $118,450.00 | 993.26K |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $10.975
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||